Publikationen 2021

1.     Althaus K., Möller P., Uzun G., Singh A., Beck A., Bettag M., Bösmüller H., Guthoff M., Dorn F., Petzold G.C., Henkes H., Heyne N., Jumaa H., Kreiser K., Limpach C., Luz B., Maschke M., Müller J.A., Münch J., Nagel S., Pötzsch B., Müller J., Schlegel C., Viardot A., Bäzner H., Wolf M., Pelzl L., Warm V., Willinek W.A., Steiner J., Schneiderhan-Marra N., Vollherbst D., Sachs U.J., Fend F., Bakchoul T. (2021) Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. HAEMATOLOGIA, 106(8): 2170-2179.

2.    Bayat B., Nielsen K.R., Bein G., Traum A., Burg-Roderfeld M., Sachs U.J. (2021) Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury. BLOOD ADV, 5(20): 3975-3985.

3.     Choi P.Y., Grace R.F., Therese Ahlen M., Nazy I., Sachs U.J., Arnold D.M., McKenzie S.E., Althaus K., Sharma R., Bakchoul T. (2021) The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters. J THROMB HAEMOST, 19(8): 2094-2095.

4.     Ehrlich K., Wilhelm J., Markart P., Weisser H., Wolff J.C., Bein G., Pak O., Barreto G., Weissmann N., Schramm F., Seeger W., Schaefer L., Kuebler W.M., Wygrecka M., and members of the CAPNETZ Study Group (2021) Sex-specific differences in plasma levels of FXII, HK, and FXIIa-C1-esterase inhibitor complexes in community-acquired pneumonia. AM J PHYSIOL-LUNG C, 321(4): L764.

5.    Esmaeili B., Bayat B., Fazlollahi M.R., Moradi L., Kalantari A., Nourbakhsh S.M.K., Pourpak Z. (2021) Identification of Antibodies against Neutrophil Surface Antigens in Two Iranian Patients with Autoimmune Neutropenia. IRAN J ALLERGY ASTHM, 20(6): 771-777.

6.     Fink C., Baal N., Wilhelm J., Sarode P., Weigel R., Schumacher V., Nettersheim D., Schorle H., Schröck C., Bergmann M., Kliesch S., Kressin M., Savai R. (2021) On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro. NEOPLASIA, 23(7): 731.

7.     Fiore M., Bayat B., Phuangtham R., Blouin L., Huguenin Y., Bein G., Santoso S. (2021) Immunization against αIIb β3 and αv β3 in Glanzmann thrombasthenia patients carrying the French Gypsy mutation. J THROMB HAEMOST, 19(1): 255-261.

8.     Hackstein H., Kalina A., Dorn B., Keil I.S., Baal N., Michel G., Brendel C., Neubauer A., Jakob T., Bein G. (2021) CD11c+ dendritic cells mediate antigen-specific suppression in extracorporeal photopheresis. CLIN EXP IMMUNOL, 203(2): 329.

9.     Luxembourg B., Henke F., Kirsch-Altena A., Sachs U., Kemkes-Matthes B. (2021) Impact of double heterozygosity for Factor V Leiden and Prothrombin G20210A on the thrombotic phenotype. THROMB RES, 200: 121-127. 

10.   Nazy I., Sachs U.J., Arnold D.M., McKenzie S.E., Choi P., Althaus K., Ahlen M.T., Sharma R., Grace R.F., Bakchoul T. (2021) Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J THROMB HAEMOST, 19(6): 1585-1588.

11.   Norris P.A.A., Segel G.B., Burack W.R., Sachs U.J., Lissenberg-Thunnissen S.N., Vidarsson G., Bayat B., Cserti-Gazdewich C.M., Callum J., Lin Y., Branch D., Kapur R., Semple J.W., Lazarus A.H. (2021) FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia. HAEMATOLOGIA, 106(1): 250-254. 

12.   Sachs U.J., Cooper N., Czwalinna A., Müller J., Pötzsch B., Tiede A., Althaus K. (2021) PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison. THROMB HAEMOSTASIS, 121(12): 1622-1627.

13.   Schneck E., Muelich M., Markmann M., Edinger F., Cooper N., Moeller A., Bein G., Hecker A., Koch C., Sander M., Wolff M. (2021) Combined Administration of Fibrinogen and Factor XIII Concentrate Does Not Improve Dilutional Coagulopathy Superiorly Than Sole Fibrinogen Therapy: Results of an In-Vitro Thrombelastographic Study. J Clin Med, 10(10): 1-12. 

14.   Tiede A., Kemkes-Matthes B., Knöbl P. (2021) Should emicizumab be used in patients with acquired hemophilia A? J THROMB HAEMOST, 19(3): 637-644. 

15.   Tiede A., Sachs U.J., Czwalinna A., Werwitzke S., Bikker R., Krauss J.K., Donnerstag F., Weißenborn K., Höglinger G., Maasoumy B., Wedemeyer H., Ganser A. (2021) Prothrombotic immune thrombocytopenia after COVID-19 vaccination. BLOOD, 138(4): 350-353. 

16.   Traum A., Hofmann C., Haas S., Schmidt S., Bein G., Sachs U.J., Bayat B. (2021) Characterization of CD177-reactive iso- and auto-antibodies. TRANSFUSION, 61(6): 1916-1922. 

17.   Uzun G., Althaus K., Singh A., Möller P., Ziemann U., Mengel A., Rosenberger P., Guthoff M., Petzold G.C., Müller J., Büchsel M., Feil K., Henkes H., Heyne N., Maschke M., Limpach C., Nagel S., Sachs U.J., Fend F., Bakchoul T. (2021) The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia. BLOOD, 138(11): 992-996.

18.   Xu X., Chen D., Ye X., Xia W., Xu Y., Chen Y., Shao Y., Deng J., Ding H., Liu J., Wang J., Ni H., Fu Y., Santoso S. (2021) Successful prenatal         therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model. BLOOD, 138(18): 1757-1767.